Skip to content
Open access

Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second‐Line Immunotherapy

Aug 2026 · International journal of urology · Vol 33 · 0 citations · 23 references
Medicine

Abstract

Prognostic stratification remains challenging in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors. The Lung Immune Prognostic Index (LIPI) may better reflect immunotherapy‐related outcomes in this setting.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.